Dr. Cynthia Bamdad

Biography

Dr. Bamdad was a pioneer in the field of biochips. She holds a B.S. in Physics and a Ph.D. in Biophysics from Harvard. While a Ph.D. student at Harvard, Dr. Bamdad invented the first electronic DNA chip and the first universal protein chip. Intellectual property surrounding these inventions and extensions thereof, also developed by Bamdad, formed the cornerstone of a California startup company, which was sold within two years to Motorola for $300 million. Dr. Bamdad is a recognized leader in the field of nanotechnology, having invented the first method to form biochip surfaces on nanoparticles and methods to use those particles in biomedical testing and drug discovery. Dr. Bamdad served on the Board of Directors of Pharmacyclics (PCYC), an anti-cancer drug company, during their turn-around, going from a valuation of $15M to a recent acquisition by Abbvie for $21B. Dr. Bamdad is the sole or co inventor inventor of over 100 patent applications in the US and foreign for novel technologies, stem cell technologies and cancer therapeutics and diagnostics. Dr. Bamdad has been the Principal Investigator on grants and contracts from the National Cancer Institute, National Institute for Mental Health, National Science Foundation, The Huntington Foundation, National Institute of General Medicine, the Defense Advance Research Projects Agency (DARPA), and the Advanced Technology Program (ATP). 

Research Interest

 Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform the field of regenerative medMinerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform the field of regenerative medicine.